Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder-a claims database analysis.
Pranjal AgrawalYeonsoo Sara LeeAurora J GrutmanKathryn DumasTaylor KohnJaden KohnAlyssa M YeeMarisa CliftonPublished in: The journal of sexual medicine (2024)
Testosterone therapy should be considered as a potential therapy for premenopausal female patients with HSDD. Further studies on the long-term effects of testosterone use must be undertaken to address disparities in the management of HSDD and to ensure patients can access treatment.
Keyphrases
- replacement therapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- health insurance
- emergency department
- postmenopausal women
- stem cells
- mental health
- smoking cessation
- healthcare
- patient reported outcomes
- cell therapy
- case control
- mesenchymal stem cells
- electronic health record
- breast cancer risk
- data analysis